Interest Rate Cut Boosts Saudi Real Estate Activity

A general view of Riyadh, Saudi Arabia. (SPA)
A general view of Riyadh, Saudi Arabia. (SPA)
TT

Interest Rate Cut Boosts Saudi Real Estate Activity

A general view of Riyadh, Saudi Arabia. (SPA)
A general view of Riyadh, Saudi Arabia. (SPA)

Experts expect the recent 50-basis-point interest rate cut by the Saudi Central Bank (SAMA) to boost the Kingdom’s real estate market.

The move is likely to direct more investor funds into property, enhance liquidity for developers, and speed up the construction of new projects.

Experts foresee a new market dynamic that could drive property prices up and sustain growth for the next six years, with demand for real estate expected to peak in the coming months.

Ahmad Al-Faqih, a real estate expert, told Asharq Al-Awsat that the rate cut will trigger a wave of delayed buying from those who postponed purchases during recent price increases. He anticipated a significant rise in demand over the next six months.

Al-Faqih also noted that recent months have seen demand outpacing supply, partly due to new buyers entering the market after changes allowing non-Saudis to own property. This trend is expected to particularly affect major cities like Riyadh.

The interest rate reduction will create strong demand for residential units, combining with buyers who delayed purchases in previous years, he stressed. This shift could reshape the market and lead to rising property prices.

Additionally, Al-Faqih noted that the changes will encourage developers to build new residential projects and attract non-Saudi investors, increasing supply but not enough to match high demand.

Lower financing costs will further motivate investment in the real estate sector.

Real estate expert Saqr Al-Zahrani told Asharq Al-Awsat that Saudi Arabia’s recent interest rate cut is also expected to boost homeownership.

With borrowing costs lower, more individuals are likely to buy homes, especially in growing areas like Riyadh and Jeddah. However, challenges in finding suitable housing for middle- and low-income groups may limit the benefits.

Al-Zahrani noted that the impact on commercial real estate might be slower to materialize due to broader economic factors. Yet, increased foreign investment and interest in projects like NEOM and Qiddiya could boost opportunities in the sector.

The rate cut will positively affect property developers by improving liquidity, allowing them to take on new projects and speed up construction, while also helping them manage rising material costs, he remarked.

Regarding property prices, Al-Zahrani cautioned that it’s hard to predict the exact effects of the rate cut. While lower borrowing costs may boost demand and drive prices up, other factors like regulations and development costs could limit this increase.

Al-Zahrani expected residential prices to rise faster than commercial prices, though not in direct correlation with the interest rate change.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.